Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05909046 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
A NA study of Gestational Diabetes and Pregnancy, High Risk, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05909046 is a NA study of Gestational Diabetes and Pregnancy, High Risk that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 104 participants, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05909046, a NA study of Gestational Diabetes and Pregnancy, High Risk, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care) to improve the frequency of post-partum diabetes screening among individuals with a pregnancy complicated by GDM. Follow up PP CARE: To engage with individuals with a history of GDM through a patient-centered mixed-methods survey and qualitative assessment to evaluate the barriers to and facilitators of Cardiovascular health (CVH) counseling and risk-reduction postpartum at the patient and healthcare system levels inclusive of Social determinants of health (SDOH) and structural factors, as well as patient preferences and perspectives on CVH and wellness interventions
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Immediate inpatient postpartum OGTT
- DIAGNOSTIC_TEST Standard of care 4-12 week postpartum OGTT
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05909046
The ClinicalTrials.gov registry entry for NCT05909046 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (67% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Immediate inpatient postpartum OGTT is the first listed.
NCT05909046 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05909046 about?
NCT05909046 is a clinical study titled "A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE". DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care) to improve the frequency of post-partum diabetes screening among individ...
What is the current status of trial NCT05909046?
This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2023-07-24. Estimated completion is 2026-06-30.
What conditions does trial NCT05909046 study?
This clinical trial studies the following conditions: Gestational Diabetes, Pregnancy, High Risk, Type2diabetes, Pregnancy in Diabetic, Pre-Gestational Diabetes.
What interventions are being tested in trial NCT05909046?
The interventions under investigation include: Immediate inpatient postpartum OGTT (DIAGNOSTIC_TEST), Standard of care 4-12 week postpartum OGTT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05909046?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05909046 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.